Literature DB >> 12439919

Mechanism of 5-fluorouracil required resistance in human hepatocellular carcinoma cell line Bel(7402).

Jing Jin1, Min Huang, Huai-Ling Wei, Geng-Tao Liu.   

Abstract

AIM: To investigate the resistance mechanism of 5-fluorouracil (5-FU) in Bel(7402)/5-FU cells which was established in our lab by in vitro continuous stepwise exposure of human hepatocellular carcinoma (HCC) cell line Bel(7402) to 5-FU.
METHODS: The expression of multidrug resistance-associated protein (MRP) and thymidylate synthase (TS) in Bel(7402) cells was detected by immonocytochemistry. The fluorescein (FLU) accumulation, an index of MRP functional activity, was determined by flow cytometry. The distribution of FLU was observed by confocal laser scanning microscope. The spectrofluorometry was used to show the intracelluar content of glutathione (GSH). Cell growth inhibition was determined by MTT assay. The activity of glutathione S-transferases (GSTs) was determined by spectrophotometry.
RESULTS: A higher expression of MRP in the Bel(7402)/5-FU cells was observed by using monoclonal mouse anti-MRP antibody, MRPr-1, in comparison with Bel(7402) cells. Bel(7402)/5-FU cells also showed a significant decrease of FLU accumulation. FLU mainly accumulated in the nucleus with a high nuclear/cytoplasmic ratio in Bel(7402) cells, whereas there was no difference of FLU accumulation between the nucleus and cytoplasm in Bel(7402)/5-FU cells. The intracellular GSH content in Bel(7402)/5-FU cells was almost 3 folds higher than that in Bel(7402) cells. Addition of D, L-buthione-S, R-sulfoximine (BSO) dose-dependently reduced the GSH content in Bel(7402)/5-FU cells, however, only a weak enhancement on the cytotoxicity of 5-FU and doxorubicin (Dox) to Bel(7402)/5-FU cells was observed. Bel(7402)/5-FU cells also exhibited 29.1 % higher total GSTs activity than Bel(7402) cells. Immunocytochemical staining by using anti-TS monoclonal antibody TS 106 showed that the level of TS in Bel(7402)/5-FU cells elevated markedly as compared with Bel(7402) cells.
CONCLUSION: The continuous exposure of Bel(7402) cells to 5-FU led to overexpression of TS and MRP, as well as increased intracellular GSH content and total GST activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12439919      PMCID: PMC4656374          DOI: 10.3748/wjg.v8.i6.1029

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  40 in total

1.  Production and characterization of monoclonal antibodies that localize human thymidylate synthase in the cytoplasm of human cells and tissue.

Authors:  P G Johnston; C M Liang; S Henry; B A Chabner; C J Allegra
Journal:  Cancer Res       Date:  1991-12-15       Impact factor: 12.701

2.  Reversal effects of antifungal drugs on multidrug resistance in MDR1-overexpressing HeLa cells.

Authors:  N Iida; K Takara; N Ohmoto; T Nakamura; T Kimura; A Wada; M Hirai; T Sakaeda; K Okumura
Journal:  Biol Pharm Bull       Date:  2001-09       Impact factor: 2.233

3.  Low-dose cisplatin and 5-fluorouracil in combination can repress increased gene expression of cellular resistance determinants to themselves.

Authors:  M Nishiyama; W Yamamoto; J S Park; R Okamoto; H Hanaoka; H Takano; N Saito; M Matsukawa; T Shirasaka; M Kurihara
Journal:  Clin Cancer Res       Date:  1999-09       Impact factor: 12.531

Review 4.  Mechanisms of cancer drug resistance.

Authors:  Michael M Gottesman
Journal:  Annu Rev Med       Date:  2002       Impact factor: 13.739

Review 5.  Resistance to cisplatin.

Authors:  S Akiyama; Z S Chen; T Sumizawa; T Furukawa
Journal:  Anticancer Drug Des       Date:  1999-04

6.  Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines.

Authors:  B van Triest; H M Pinedo; Y van Hensbergen; K Smid; F Telleman; P S Schoenmakers; C L van der Wilt; J A van Laar; P Noordhuis; G Jansen; G J Peters
Journal:  Clin Cancer Res       Date:  1999-03       Impact factor: 12.531

Review 7.  Novel mechanisms of drug resistance in leukemia.

Authors:  D D Ross
Journal:  Leukemia       Date:  2000-03       Impact factor: 11.528

Review 8.  Anticancer drug resistance in primary human brain tumors.

Authors:  M Bredel
Journal:  Brain Res Brain Res Rev       Date:  2001-04

9.  Characterization of vincristine transport by the M(r) 190,000 multidrug resistance protein (MRP): evidence for cotransport with reduced glutathione.

Authors:  D W Loe; R G Deeley; S P Cole
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

10.  Thymidylate synthase expression and activity: relation to S-phase parameters and 5-fluorouracil sensitivity.

Authors:  J F Mirjolet; M Barberi-Heyob; J L Merlin; S Marchal; M C Etienne; G Milano; P Bey
Journal:  Br J Cancer       Date:  1998-07       Impact factor: 7.640

View more
  11 in total

1.  Priming cancer cells for drug resistance: role of the fibroblast niche.

Authors:  Wei Bin Fang; Min Yao; Nikki Cheng
Journal:  Front Biol (Beijing)       Date:  2014-02-01

Review 2.  Interplay of autophagy and cancer stem cells in hepatocellular carcinoma.

Authors:  Magdelyn Mei-Theng Wong; Hui-Yin Chan; Norazlin Abdul Aziz; Thamil Selvee Ramasamy; Jan-Jin Bong; Ewe Seng Ch'ng; Subasri Armon; Suat-Cheng Peh; Sin-Yeang Teow
Journal:  Mol Biol Rep       Date:  2021-04-24       Impact factor: 2.316

3.  Piper betle leaf extract enhances the cytotoxicity effect of 5-fluorouracil in inhibiting the growth of HT29 and HCT116 colon cancer cells.

Authors:  Pek Leng Ng; Nor Fadilah Rajab; Sue Mian Then; Yasmin Anum Mohd Yusof; Wan Zurinah Wan Ngah; Kar Yong Pin; Mee Lee Looi
Journal:  J Zhejiang Univ Sci B       Date:  2014-08       Impact factor: 3.066

4.  Toxicities and therapeutic effect of 5-fluorouracil controlled release implant on tumor-bearing rats.

Authors:  Yin-Cheng He; Ji-Wei Chen; Jun Cao; Ding-Yu Pan; Jian-Guo Qiao
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

5.  Correlation of expression of multidrug resistance protein and messenger RNA with 99mTc-methoxyisobutyl isonitrile (MIBI) imaging in patients with hepatocellular carcinoma.

Authors:  Hai Wang; Xiao-Ping Chen; Fa-Zu Qiu
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

6.  The noncytotoxic dose of sorafenib sensitizes Bel-7402/5-FU cells to 5-FU by down-regulating 5-FU-induced Nrf2 expression.

Authors:  Suna Zhou; Wenguang Ye; Xiaoyi Duan; Mingxin Zhang; Jiansheng Wang
Journal:  Dig Dis Sci       Date:  2013-01-12       Impact factor: 3.199

7.  Changes in intracellular redox status influence multidrug resistance in gastric adenocarcinoma cells.

Authors:  DE-Jun Tai; Wen-Sen Jin; Cheng-Si Wu; Hong-Wei Si; Xian-Dong Cao; Ai-Jun Guo; Jia-Cong Chang
Journal:  Exp Ther Med       Date:  2012-05-24       Impact factor: 2.447

8.  Caffeine enhances the anti-tumor effect of 5-fluorouracil via increasing the production of reactive oxygen species in hepatocellular carcinoma.

Authors:  Zhilei Wang; Chengxin Gu; Xinrui Wang; Yating Lang; Yanqin Wu; Xiaoqin Wu; Xifei Zhu; Kunyuan Wang; Hui Yang
Journal:  Med Oncol       Date:  2019-10-29       Impact factor: 3.064

9.  Histone acetyltransferase PCAF accelerates apoptosis by repressing a GLI1/BCL2/BAX axis in hepatocellular carcinoma.

Authors:  X Gai; K Tu; C Li; Z Lu; L R Roberts; X Zheng
Journal:  Cell Death Dis       Date:  2015-04-09       Impact factor: 8.469

10.  The synergistic in vitro and in vivo antitumor effect of combination therapy with salinomycin and 5-fluorouracil against hepatocellular carcinoma.

Authors:  Fan Wang; Weiqi Dai; Yugang Wang; Miao Shen; Kan Chen; Ping Cheng; Yan Zhang; Chengfen Wang; Jingjing Li; Yuanyuan Zheng; Jie Lu; Jing Yang; Rong Zhu; Huawei Zhang; Yingqun Zhou; Ling Xu; Chuanyong Guo
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.